Delivery Order SPE2DB22D2206-SPE2DB25FDZ61

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of KERENDIA 10 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The firm-fixed-price delivery order, valued at $6,855.96, has a completion date of December 13, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 90S to the Defense Logistics Agency (DLA). The $4,859.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.99 firm fixed-price delivery order is for the supply of Kerendia 10 mg tablets. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.75 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,435.81 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of March 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.98, is a Delivery Order for the supply of Kerendia 10 mg tablets. The contract has no set-aside designation, indicating open competition. It is a Firm Fixed Price contract with a period of performance through July 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $13,613.22 and an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of KERENDIA 20 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 4, 2024, with a ceiling value of $1,135.08 and a completion date of December 5, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, valued at $1,146.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set-aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDZ61
    Delivery Order

This federal contract award is for the delivery of KERENDIA 10 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,697.07, is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 30, 2024.

The contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 1/28/25, 12:18 PM